Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Eline J Arends"'
Autor:
Eline J. Arends, Soufian Meziyerh, Dirk Jan A.R. Moes, Sylvia W.A. Kamerling, Sandra van der Kooy, Natacha S. Ogando, Eric J. Snijder, Martijn van Hemert, Leo G. Visser, Mariet C.W. Feltkamp, Eric C.J. Claas, Ton J. Rabelink, Cees van Kooten, Aiko P.J. de Vries, Y.K. Onno Teng
Publikováno v:
Kidney International Reports, Vol 8, Iss 12, Pp 2654-2664 (2023)
Introduction: Immunocompromised kidney patients are at increased risk of prolonged SARS-CoV-2 infection and related complications. Preclinical evidence demonstrates a more potent inhibitory effect of voclosporin on SARS-CoV-2 replication than tacroli
Externí odkaz:
https://doaj.org/article/edf3ee210dfc412e92ec7a06d4558669
Autor:
Mieke van Schaik, Eline J. Arends, Darius Soonawala, Ellen van Ommen, Karina de Leeuw, Maarten Limper, Pieter van Paassen, Tom W. J. Huizinga, René E. M. Toes, Cees van Kooten, Joris I. Rotmans, Ton J. Rabelink, Y. K. Onno Teng
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-10 (2022)
Abstract Background Belimumab, an anti-B-cell activating factor antibody, is approved for the treatment of auto-antibody positive systemic lupus erythematosus with a high degree of disease activity. Anti-CD20 B cell depletion with rituximab is used i
Externí odkaz:
https://doaj.org/article/40ea93bde1b948b18e6192b68708ecea
Autor:
Laura S. van Dam, Jelle M. Oskam, Sylvia W. A. Kamerling, Eline J. Arends, O. W. Bredewold, Magdalena A. Berkowska, Jacques J. M. van Dongen, Ton J. Rabelink, Cees van Kooten, Y. K. Onno Teng
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
BackgroundB-cell depletion with rituximab (RTX) is an effective treatment for anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV) patients. Nevertheless, relapses are frequent after RTX, often preceded by B-cell repopulation sug
Externí odkaz:
https://doaj.org/article/88a01c1caada4b079f0609fa32b551e0
Autor:
Natacha S. Ogando, Erik Metscher, Dirk Jan A. R. Moes, Eline J. Arends, Ali Tas, Jennifer Cross, Eric J. Snijder, Y. K. Onno Teng, Aiko P. J. de Vries, Martijn J. van Hemert
Publikováno v:
Transplant International, 35. FRONTIERS MEDIA SA
Kidney transplant recipients (KTRs) are at increased risk for a more severe course of COVID-19, due to their pre-existing comorbidity and immunosuppression. Consensus protocols recommend lowering immunosuppression in KTRs with severe acute respirator
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ada6463373482fc66da42fbb4208cf5
https://doi.org/10.3389/ti.2022.10369
https://doi.org/10.3389/ti.2022.10369
Autor:
Eline J Arends, Mihaela Zlei, Christopher M Tipton, Zgjim Osmani, Fenna de Bie, Sylvia W A Kamerling, Ton Rabelink, Ignacio Sanz, Jacques J M Van Dongen, Cees van Kooten, Yeo K O Teng
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS Belimumab (BEL), a recombinant human monoclonal antibody directed against B-cell activating factor (BAFF), is the first approved biological agent for patients with systemic lupus erythematosus (SLE) and a high level of disease act
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a0b41e245dac5f8927ca6389dc0c352
https://doi.org/10.1093/ndt/gfac067.045
https://doi.org/10.1093/ndt/gfac067.045
Autor:
S.W. Kamerling, Ton J. Rabelink, Paul L A van Daele, Tom W J Huizinga, Argho Ray, T. Kraaij, Jaap A. Bakker, Cees van Kooten, O.W. Bredewold, Laura van Dam, Hans Scherer, Y.K. Onno Teng, Eline J Arends
Publikováno v:
Poster presentations.
Background Anti-CD20 B-cell depletion has not shown superior efficacy to standard immunosuppression in patients with systemic lupus erythematosus (SLE). Besides trial design, potential explanations are incomplete B-cell depletion in relation to subst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d502709d4499cd64833bfd875857bab8
https://doi.org/10.1136/lupus-2020-eurolupus.171
https://doi.org/10.1136/lupus-2020-eurolupus.171